Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Nortran Pharmaceutical -NRT.V -- Ignore unavailable to you. Want to Upgrade?

To: David Culver who wrote (317)	3/30/1998 10:40:00 AM
From: Paul S.	Respond to of 1185

Thanks David, I think I would still like to subscribe, do you have the info as to how and what it costs. Obviously the decision to invest in any stock is ultimately up to the purchaser, but I would like to be made aware of potential winners like Nortran at the $.90 level. I just received this in my email from perspectives, an internet news letter: Nortran Pharmaceuticals (NRT) nortran.com Last week we stated that this company had some good things going on, again in the Pharmaceutical sector which is hot right now. We also stated that this stock should be bought when it breaks to new highs. It did that on Wednesday, hitting a high of $1.62. Closed Friday at $1.85 and looks like it has pretty good chance of going higher still.